Información del artículo
La polineuropatía diabética (DPN) es una de las complicaciones crónicas más frecuentes en los pacientes con diabetes, sinónimo de neuropatía diabética, y representa una de las causas principales para presentar úlceras en los pies y amputaciones de miembros inferiores (LEA). La DPN comienza de forma habitual con una disfunción de los nervios, con la presencia de signos, pero de forma asintomática. En la prevención es prioritario el estricto control glucémico y de otros factores de riesgo cardiovascular, que incluyen la dislipemia, la hipertensión arterial, el tabaco, la circunferencia de la cintura y el consumo de grasa. Las estrategias preventivas para reducir la aparición de úlceras en los pies y LEA están dirigidas al diagnóstico temprano de DPN con el diapasón de 128 Hz, el palillo puntiagudo y los reflejos aquíleos, el neurotensiómetro y el monofilamento de 10 g, y la intervención basada en el desarrollo de un programa estructurado y continuado de educación y tratamiento.
Palabras clave:
Polineuropatía diabética
Pie en riesgo
Amputación no traumática
Programa para el cuidado del pie
Diabetic polyneuropathy (DPN), also called diabetic neuropathy, is one of the most frequent complications of diabetes mellitus and remains a major cause of foot ulcers and lower extremity amputations (LEAs). DPN often begins with silent nerve dysfunction and abnormal signs but with few or no symptoms. Factors crucial to prevention are control of blood glucose levels and other cardiovascular risk factors such as dyslipidemia, hypertension, smoking, waist circumference, and fat consumption. Prevention strategies to reduce foot ulcers and LEAS focus on the early detection of DPN, involving the use of the 128 Hz turning fork, pin-prick and Achilles reflex testing, tensometer and 10-g monofilament, and intervention based on continuing and well-structured education and treatment programs.
Key words:
Diabetic polyneuropathy
Foot at risk
Non-traumatic amputation
Foot care program
El Texto completo está disponible en PDF
Bibliografía
[1.]
J. Apelqvist, J. Larsson, C.D. Agardh.
Long-term prognosis for diabetic patients with foot ulcers.
J Intern Med, 233 (1993), pp. 485-491
[2.]
D. Bild, J. Selby, P. Sinnock, W. Browner, P. Braveman, J. Showstack.
Lower-extremity amputation in people with diabetes.
Diabetes Care, 12 (1989), pp. 24-29
[3.]
F.J. Thomson, A. Velves, H. Ashe, E.A. Knowles, J. Gem, M.G. Walker, et al.
A team approach to diabetic foot care: the Manchester experience.
Foot, 1 (1991), pp. 75-82
[4.]
C. Patout, J. Birke, R. Horswell, D. Williams, F. Cerise.
Effectiveness of a comprehensive diabetes lower-extremity amputation prevention program in a predominantly low-income African-American population.
Diabetes Care, 23 (2000), pp. 1339-1342
[5.]
A.J. Boulton.
The pathogenesis of diabetic foot problems: an overview.
Diabetic Medicine, 13 (1996), pp. S12-S16
[6.]
A.L. Calle Pascual, M.J. Redondo, M. Ballesteros, M.A. Martínez-Salinas, J.A. Díaz, P. De Matía, et al.
Nontraumatic lower extremity amputations in diabetic and non-diabetic subjects in Madrid, Spain.
Diabetes Metab, 23 (1997), pp. 519-523
[7.]
A.L. Calle Pascual, N. García de la Torre, I. Moraga, J.A. Díaz, A. Durán, G. Moñux, et al.
Epidemiology of nontraumatic lower-extremity amputation in Area 7, Madrid, between 1989 and 1999.
Diabetes Care, 24 (2001), pp. 1686-1688
[8.]
A.L. Calle Pascual, A. Durán, A. Benedi, M.I. Calvo, A. Charro, J.A. Díaz, et al.
A preventive foot care programme for people with diabetes with different stages of neuropathy.
Diab Res Clin Pract, 57 (2002), pp. 111-117
[9.]
A.L. Calle Pascual, A. Durán, A. Benedeti, M.I. Calvo, A. Charro, J.A. Díaz.
Reduction in foot ulcer incidente. Relation to compliance with a prophylactic foot care program.
Diabetes Care, 24 (2001), pp. 405-407
[10.]
P. Martín, J.A. Díaz, A. Durán, N. García de la Torre, A. Benedí, I. Calvo, et al.
Pie diabético.
Endocrinol Nutr, 53 (2006), pp. 60-67
[11.]
A. Boulton, A. Vinik, J. Arezzo, V. Brii, E. Feldman, R. Freeman, et al.
Diabetic neuropathies.
Diabetes Care, 28 (2005), pp. 956-962
[12.]
P.J. Dyck.
Severity and staging of diabetic polyneuropathy.
Textbook of diabetic neuropathy, Thieme, (2003),
[13.]
J. Cabezas-Cerrato, Neuropathy Spanish Study Group of the Spanish Diabetes Society.
The prevalence of clinical diabetic polyneuropahty in Spain: a study in primare care and hospital clinic groups.
Diabetología, 41 (1998), pp. 1263-1269
[14.]
S. Tesfaye, L.K. Stevens, J.M. Stephenson, J.H. Fuller, M. Plater, C. Ionescu-Tirgoviste, The EURODIAB IDDM Study Group.
Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study.
Diabetología, 39 (1996), pp. 1377-1384
[15.]
The Diabetes Control and Complications Trial Research Group (DCCT).
The effect of intensive treatment of diabetes on the development and progression of long term complications in the diabetes control in insulin dependent diabetes mellitus.
N Engl J Med, 329 (1993), pp. 977-986
[16.]
UK Prospective Diabetes Study (UKPDS) Group.
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).
Lancet, 352 (1998), pp. 837-853
[17.]
Y. Ohkubo, H. Kishikawa, E. Araki.
Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.
Diabetes Res Clin Pract, 28 (1995), pp. 103-107
[18.]
S. Tesfaye, N. Chaturvedi, S. Eaton, J.D. Ward, C. Manes, C. Ionescu-Tirgoviste, For the EURODIAB Prospective Complications Study Group, et al.
Vascular risk factors and diabetic neuropathy.
N Engl J Med, 352 (2005), pp. 341-350
[19.]
P. Gaede, P. Vedel, N. Larsen, G.V.H. Jensen, H.H. Parving, O. Pedersen.
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.
N Engl J Med, 348 (2003), pp. 383-393
[20.]
The Diabetes and Nutrition Study Group of the Spanish Diabetes Association (GSEDNu).
Diabetes Nutrition and complications Trial (DNCT). Diet and risk of microangiopathy progression: the role of polyunsaturated fatty acids and monounsaturated fatty acids consumption.
Obesity and Metabolism, 2 (2006), pp. 6-12
[21.]
The Diabetes and Nutrition Study Group of the Spanish Diabetes Association (GSEDNu).
Diabetes Nutrition and Complications Trial. Adherence to the ADA nutritional recommendations, targets of metabolic control, and onset of diabetes complications. A 7-year, propective, population-based, observational multicenter study.
J Diabet Compl, 20 (2006), pp. 361-366
[22.]
Grupo de Nutrición de la Sociedad Española de Diabetes (GSEDNu).
Estudio sobre la nutrición en la diabetes y las complicaciones (DNCT): hábitos nutricionales en la población con diabetes en España y su relación con la presencia de neuropatía.
Endocrinol Nutr, 52 (2005), pp. 476-483
[23.]
A.L. Calle Pascual, I. Runkle, J.A. Díaz, A. Durán, L. Romero.
Técnicas de exploración de la sensibilidad en la patología del pie.
Av Diabetol, 22 (2006), pp. 42-49
[24.]
M. Smieja, D. Hunt, D. Edelman, E. Etchells, J. Cornuz, D. Simel.
Clinical examination for the detection of protective sensation in the feet of diabetic patients.
J Gen Intern Med, 14 (1999), pp. 418-424
[25.]
S. Kumar, D.J. Fernando, A. Veves, E.A. Knowles, M.J. Young, A.J. Boulton.
Semmens Weinstein monofilament: a simple effective and inexpensive screening device for identifying patients at risk of foot ulceraton.
Diab Res Clin Pract, 13 (1991), pp. 63-68
[26.]
J.W. Meijer, A.J. Smit, J.D. Lefrandt, J.H. Van der Hoeven, K. Hoogenberg, T.P. Links.
Back to basics in diagnosing diabetic polyneuropathy with the tuning fork!.
Diabetes Care, 28 (2005), pp. 2201-2205
[27.]
American Diabetes Association.
Preventive foot care in people with diabetes.
Diabetes Care, 26 (2003), pp. S78-S79
[28.]
American Diabetes Association.
Peripheral arterial disease in people with diabetes.
Diabetes Care, 26 (2003), pp. 3333-3341
[29.]
A.L. Calle Pascual, L. Romero, A. Durán, J.A. Díaz, H. Manrique, A. Charro.
Silent peripheral vascular disease is prevalent in people with diabetic neuropathy.
Av Diabetol, 20 (2004), pp. 123-126
[30.]
D.T. Williams, K.G. Harding, P. Price.
An evaluation of the efficacy of methods used in screening for lower-limb arterial disease in diabetes.
Diabetes Care, 28 (2005), pp. 2206-2210
[31.]
A.L. Calle Pascual, A. Durán, J.A. Díaz, G. Moñux, F.J. Serrano, N. García de la Torre, et al.
Comparison of peripheral arterial reconstruction in diabetic and non-diabetic patients: a prospective clinic-base study.
Diab Res Clin Prac, 53 (2001), pp. 129-136
[32.]
J. Plank, W. Hass, I. Rakovac, R. Sommer, A. Siebenhofer, T. Pieber.
Evaluation of the impact of chiropodist care in the secondary prevention of foot ulcerations in diabetic subjects.
Diabetes Care, 26 (2003), pp. 1691-1695
[33.]
Grupo de Trabajo Internacional sobre el Pie Diabético. Consenso Internacional sobre el Pie Diabético; 2001.
[34.]
L.A. Lavery, D. Armstrong, R.P. Wunderlich, M.J. Moler, C.S. Wendel, B.A. Lipsky.
Risk factors for foot infections in individuals with diabetes.
Diabetes Care, 29 (2006), pp. 1288-1293
[35.]
P.R. Wraigth, S.M. Lawrence, D.A. Campbell, P.G. Colman.
Creation of a multidisciplinary, evidence based, clinical guideline for the assessment, investigation and management of acute diabetes related complications.
Diabet Med, 22 (2004), pp. 127-136
Copyright © 2008. Sociedad Española de Endocrinología y Nutrición